Global /Taiwan /Healthcare /Medical Devices /6955

Bonraybio Co., Ltd.

6955

• TWSE: 6955 • Delayed

167.00TWD 1.8%

5.29 USD

As of 6 June 2026, Bonraybio Co., Ltd. has a market cap of $131.67M USD, ranking #23698 globally and #1216 in Taiwan. It ranks #2130 in the Healthcare sector, and #442 in the Medical Devices industry.

Global Rank

23698

Country Rank

1216

Sector Rank

2130

Industry Rank

442

Key Stats

Market Cap

$131.67MUSD

4.14B TWD

Enterprise Value

$113.64MUSD

3.59B TWD

Revenue (TTM)

$9.74MUSD

306.31M TWD

EBITDA (TTM)

$3.45MUSD

108.95M TWD

Net Income (TTM)

$3.26MUSD

102.51M TWD

EBITDA Margin

36%

Profit Margin

33%

PE Ratio

40.5

PS Ratio

13.5

PB Ratio

6.5

EV/EBITDA

32.0

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Medical Devices

CEO

Zhenteng Xu open_in_new

Founded

2015

Website

bonraybio.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1.8%	-3.3%	-1.2%	-2.4%	-3.5%	11%	32%	26%	26%

News

Markets

Exchange	Ticker	Price	Quotes
Taiwan Stock Exchange (TWSE) MIC: XTAI PRIMARY	6955 邦睿生技股份有限公司 ISIN: TW0006955008 Shares Out.: Shares Outstanding: 24.801M¹ TV: TradingView: TWSE: 6955 SA: Stock Analysis: TPE: 6955 YF: Yahoo Finance: 6955.TW GF: Google Finance: TPE: 6955 BA: Barron's: 6955 MS: Morningstar: XTAI: 6955	167.00 TWD	TV: TradingView: TWSE: 6955 SA: Stock Analysis: TPE: 6955 YF: Yahoo Finance: 6955.TW GF: Google Finance: TPE: 6955 BA: Barron's: 6955 MS: Morningstar: XTAI: 6955

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Bonraybio Co., Ltd.

Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also provides consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X QC Reticles, X QC video tools, and X QC beads; sperm DNA fragmentation test kits; and S10 data consolidation software. Bonraybio Co., Ltd. was founded in 2015 and is based in Taichung, Taiwan.

Similar Companies

Industry: Medical Devices (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
Sunmax Biotechnology Co., Ltd. TPEX: 4728	$670.9M 21.1B TWD 410%	29.1	Taiwan
TaiDoc Technology Corp. TWSE: 4736	$378.99M 11.92B TWD 188%	8.3	Taiwan
YD Bio Ltd. NASDAQ: YDES	$364.92M 177%	-	Taiwan
United Orthopedic Corp. TPEX: 4129	$303.5M 9.55B TWD 131%	17.5	Taiwan
Bioteque Corp. TPEX: 4107	$255.54M 8.04B TWD 94%	15.0	Taiwan
Hi-Clearance Inc. TPEX: 1788	$191.77M 6.03B TWD 46%	16.4	Taiwan

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 132K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 122K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 121K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 96K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 92K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 77K%	22.2	Ireland

chevron_leftBack